An 8-week treatment course with cilostazol as an adjunct to risperidone demonstrates a favourable safety and efficacy profile in patients with schizophrenia, improving primary negative symptoms without resulting in serious adverse events requiring medical intervention, a study has shown.
One-third of dementia cases globally can be prevented by addressing nine lifestyle factors at different stages of life, beginning from better education during childhood, according to a report from The Lancet Commission on Dementia Prevention, Intervention, and Care.
Young patients receiving active attention bias modification therapy (ABMT) exhibit improved clinical benefits, a recent study has shown. In addition, ABMT appears to be most effective for patients with abnormal amygdala-insula connectivity.
In low- and middle-income countries (LMICs), lifetime self-reported arthritis is significantly associated with mental health comorbidities like depression subtypes and anxiety, a recent study has shown.
There appears to be an association between patterns of reproductive lifetime exposure to oestrogen and the risk of high depressive symptoms during the menopausal transition (MT) and initial postmenopausal years, such that longer exposure to oestrogen is protective, according to a recent study.
The use of lithium treatment appears to be effective in patients with bipolar disorder with suspected suicidal intentions, according to a recent study. However, risk for suicide is only one of the many considerations when providing clinical care.
Treatment with the arginine vasopressin receptor 1A (V1a) antagonist, RG7713, induces subtle improvements in social communication surrogates including eye tracking and affective speech recognition, among others, in adults with high-functioning autism spectrum disorder (ASD), a study has shown.
People who worked long hours, with 55 working hours/week or more, have a higher risk of developing atrial fibrillation (AF) than those who worked standard hours (35–40 hours/week), according to a pooled analysis of data from the IPD-Work* Consortium.
Memantine hydrochloride may be effective in the treatment of core social and cognitive deficits among adults with high-functioning autism spectrum disorder, based on a prospective, 12-week, open-label trial.
A meta-analysis of individual patient data shows that the effect size of transcranial direct current stimulation (tDCS) in acute major depressive episodes is comparable with repetitive transcranial magnetic stimulation and antidepressant drug treatment.